Mentholatum Deep Heating Rub

Description

Deep Heating PDP is a therapeutic agent designed for the application of heat to the skin and underlying tissues. It is formulated to provide deep tissue heating, which may aid in the relief of muscle stiffness and pain. The product is characterized by its specific formulation that enhances the penetration of heat into the targeted areas.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints due to conditions such as arthritis, strains, simple backache, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. The application should be performed with clean hands, ensuring that the area is dry before applying the product.

For children under 2 years of age, it is advised to consult a physician prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

Application to the eyes or mucous membranes is prohibited due to the potential for irritation. It should not be applied to wounds or damaged skin to avoid exacerbating injury or delaying healing. Tight bandaging is contraindicated as it may restrict circulation. The product should not be used in conjunction with heating pads or other heat sources, or immediately following a shower or bath, as this may increase absorption and risk of adverse effects. Additionally, concurrent use with other external analgesic products is contraindicated to prevent potential interactions and enhance the risk of side effects.

Warnings and Precautions

For external use only. This product should be utilized strictly as directed to ensure safety and efficacy. It is imperative to avoid contact with the eyes and mucous membranes, as well as to refrain from applying the product to wounds or damaged skin. Bandaging should not be done tightly, and the product should not be used in conjunction with heating pads, other heat sources, or immediately following a shower or bath. Additionally, the use of this product alongside other external analgesic products is contraindicated.

Healthcare professionals should advise patients to discontinue use and seek medical attention if any of the following occur: the condition worsens; excessive irritation, burning, or discomfort of the skin develops; symptoms persist for more than 7 days or resolve only to recur within a few days. Pregnant or breastfeeding individuals should consult a healthcare professional prior to use.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event that the condition worsens, or if excessive irritation, burning, or discomfort of the skin develops, it is advised to stop use and consult a healthcare professional. Additionally, if symptoms persist for more than 7 days or clear up and then recur within a few days, patients should seek medical advice.

It is also important for patients who are pregnant or breastfeeding to consult a healthcare professional before using this product to ensure safety for both themselves and their child.

Drug Interactions

The concomitant use of this medication with other external analgesic products is contraindicated. Co-administration may lead to an increased risk of adverse effects, including localized irritation or systemic toxicity. It is advised to avoid such combinations to ensure patient safety and therapeutic efficacy. Monitoring for any signs of adverse reactions is recommended if there is a potential for exposure to multiple analgesic agents.

Packaging & NDC

Below are the non-prescription pack sizes of Mentholatum Deep Heating Rub (menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area no more than 3 to 4 times daily. For infants and children under 2 years of age, it is advised to consult a healthcare professional before use.

Geriatric Use

There is no specific information regarding the use of Mentholatum Deep Heating Rub Extra Strength in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution when recommending this product to geriatric patients, considering the lack of data on its safety and efficacy in this population. Monitoring for any adverse effects or unusual responses is advisable when this product is used in elderly individuals.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare providers can offer guidance based on individual circumstances and the latest clinical data.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to stop using the product and consult a doctor if their condition worsens, if they experience excessive irritation, burning, or discomfort of the skin, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

For patients who are pregnant or breastfeeding, it is essential to recommend that they consult a healthcare professional before using the product.

When using this product, patients should be instructed to use it only as directed. They should avoid contact with the eyes and mucous membranes, and not apply it to wounds or damaged skin. Additionally, patients should not bandage the area tightly, use it in conjunction with heating pads or other heat sources, or apply it immediately after a shower or bath. It is also important to advise patients against using this product in combination with other external analgesic products.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Additionally, once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years, it is advised to consult a doctor before use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Mentholatum Deep Heating Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)